Omega-3 Fatty Acids
Also known as: EPA, DHA, Fish oil, Eicosapentaenoic acid, Docosahexaenoic acid
Essential fats from fish and algae (EPA and DHA) that support heart, brain, and eye health.

Omega-3 is a family of fats, not one interchangeable ingredient. EPA and DHA lower triglycerides at clinically relevant doses, while cardiovascular, pregnancy, and joint outcomes vary by food versus supplement, dose, formulation, population, and endpoint.1, 2
- EPA and DHA come mainly from fatty fish and algae; ALA comes from plants1, 2
- DHA is a major structural fat in the brain and retina1, 2
- Strongest evidence: lowering very high triglycerides1, 2
- No official RDA; adequate intake for ALA is 1.6 g (men) / 1.1 g (women) daily1, 2
What is Omega-3 Fatty Acids?
Omega-3s are essential fatty acids, meaning the body needs them but cannot synthesize them. There are three main types: ALA from plants, and EPA and DHA from marine sources. The body converts only a small fraction of ALA into EPA and DHA, so direct intake of EPA/DHA — from fish, seafood, or supplements — matters. Omega-3s are incorporated into cell membranes throughout the body and are especially concentrated in the brain and retina, where DHA makes up a substantial share of structural fat.1
Where it comes from
Natural sources
- Fatty fish: salmon, mackerel, sardines, herring, anchovies
- Fish oil and krill oil supplements
- Algal oil (the original source of EPA/DHA, popular with vegans)
- ALA sources: flaxseed, chia seeds, walnuts, canola oil
What it does in products
Benefits
Lowering high triglycerides
strong evidenceEPA/DHA reliably lower blood triglycerides at doses of 2–4 grams daily, and prescription omega-3 products are FDA-approved for very high triglycerides.1, 2
EPA/DHA lower triglycerides, but prescription products, doses used for severe hypertriglyceridemia, and ordinary fish-oil supplements are not interchangeable.
Heart health
moderate evidencePregnancy and infant development
moderate evidenceDHA accumulates in the fetal brain during the third trimester, and adequate maternal intake supports infant visual and cognitive development. Prenatal supplements commonly include 200–300 mg DHA.1, 4
Cochrane evidence supports some pregnancy outcomes, but it does not establish broad cognitive advantages for every child or every prenatal product.
Joint comfort
limited evidenceBecause omega-3s modulate inflammatory signaling, some trials find modest improvements in joint pain and stiffness, particularly in rheumatoid arthritis, where evidence is stronger.2, 5
The clearest joint signal is in rheumatoid arthritis and is modest; results do not establish a general treatment for osteoarthritis or nonspecific joint pain.
Evidence scope and limitations
This review separates food intake, nonprescription EPA/DHA supplements, and prescription omega-3 products; ALA evidence is not treated as equivalent to EPA/DHA evidence.
- Dose, EPA-to-DHA ratio, oxidation, baseline diet, and cardiovascular risk change the result.
- Prescription triglyceride-lowering evidence should not be used to advertise an ordinary low-dose fish-oil capsule.
Evidence last checked: 2026-09-26
Side effects & safety
Safety considerations
- DHA is recommended during pregnancy. Choose molecularly distilled or third-party-tested products, and limit intake from large predatory fish due to mercury.
- High-dose omega-3s can add to the effect of blood thinners such as warfarin; doses above 3 g per day should be discussed with a doctor.
- Omega-3s can slightly raise LDL cholesterol in some people, an effect usually considered clinically minor.
- Not for: Allergy to fish or shellfish (use algal oil instead)
Amounts studied & product use
These figures describe research or common product use, not a personal dose or treatment recommendation.
In supplement studies and products
Human trials report the actual EPA and DHA amount rather than total fish-oil weight and use widely varying doses. Triglyceride-lowering evidence comes from gram-level, often prescription, EPA/DHA regimens under clinical supervision; it does not define a universal wellness dose.
Regulatory status
- Dietary supplement under DSHEA. The FDA permits qualified health claims for EPA/DHA and reduced risk of coronary heart disease. Prescription-strength omega-3 ethyl esters are approved drugs for very high triglycerides.
- GRAS (generally recognized as safe) for food use.
Fish oil vs krill oil vs algal oil
Fish oil is the classic and most studied source of EPA/DHA. Krill oil delivers omega-3s bound to phospholipids and also contains astaxanthin; it may be absorbed somewhat more efficiently, but far fewer long-term trials exist. Algal oil is the vegan alternative — algae are where fish get their EPA/DHA in the first place — and has a comparable effect on blood levels at equivalent doses.
1Frequently asked questions
How much omega-3 should I take daily?
For general wellness, 250–500 mg of combined EPA+DHA is a common target; official bodies generally recommend at least 2 servings of fatty fish per week. If your goal is lowering triglycerides, clinical doses of 2–4 g daily are used, but that should be done under medical supervision.1, 2
What is the difference between EPA and DHA?
Both are long-chain marine omega-3s. DHA is more concentrated in brain and retinal tissue and is emphasized during pregnancy and early life, while EPA is more closely associated with anti-inflammatory signaling and triglyceride lowering. Most supplements contain both.1, 2
The bottom line
Omega-3 evidence is indication-specific: triglyceride lowering is established, while broader heart and joint claims are more conditional. Food, ordinary supplements, and prescription products should not be treated as equivalent.
References
- Omega-3 Fatty Acids: Health Professional Fact Sheet. NIH Office of Dietary Supplements (2025) · government guidance
- Omega-3 Supplements: In Depth. National Center for Complementary and Integrative Health (2025) · government guidance
- FDA announces qualified health claims for EPA and DHA omega-3 consumption. U.S. Food and Drug Administration (2019) · government guidance
- Omega-3 fatty acid addition during pregnancy. Cochrane Database of Systematic Reviews (2018) · systematic review · PMID 30480773
- Omega-3 polyunsaturated fatty acids in rheumatoid arthritis: a systematic review and meta-analysis. Nutrition (2018) · meta analysis · PMID 28965775
Revision history
- Replaced search-result citations with exact sources, mapped claims to evidence, and reassessed evidence strength.